However, other randomized controlled trials have not found any benefit of citicoline treatment in the management of acute ischemic stroke (98, 99), including a recent trial evaluating its effects when provided immediately following endovascular thrombectomy (i.e., recanalization therapy) and continued for 42 days (100)
All protocols below are based on Phase 2 clinical-trial data and self-reported community experience
ShenLZhangKFengCChenYLiSIqbalJet al
Every individuals journey is unique
Large-scale cardiovascular outcome trials have demonstrated that certain GLP-1 agonists, including liraglutide, semaglutide, and dulaglutide, reduce the risk of major adverse cardiovascular events (MACE) such as myocardial infarction, stroke, and cardiovascular death in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors